Caroline Tsai - Feb 28, 2023 Form 4 Insider Report for Fidelity National Information Services, Inc. (FIS)

Role
CEVP CLO and Corp Affairs
Signature
/s/ Charles H. Keller, attorney-in-fact for Caroline Tsai
Stock symbol
FIS
Transactions as of
Feb 28, 2023
Transactions value $
$8,389,428
Form type
4
Date filed
3/2/2023, 04:54 PM
Previous filing
Mar 2, 2022
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIS Common Stock Options Exercise $0 +2.63K $0.00 2.63K Mar 1, 2023 Direct
transaction FIS Common Stock Tax liability -$43.7K -689 -26.25% $63.37 1.94K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIS Restricted Stock Units Options Exercise $0 -2.63K -33.33% $0.00 5.25K Mar 1, 2023 Common Stock 2.63K $0.00 Direct F2, F3
transaction FIS Restricted Stock Units Award $0 +24.9K $0.00 24.9K Feb 28, 2023 Common Stock 24.9K $0.00 Direct F2, F3
transaction FIS Stock Option (Right to Buy) Award $8.43M +133K $63.37 133K Feb 28, 2023 Common Stock 133K $63.37 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares to satisfy withholding tax obligation for Restricted Stock Unit vesting.
F2 Each restricted stock unit represents a contingent right to receive one share of FIS common stock.
F3 The restricted stock units vest and distribute in three equal annual installments on each anniversary date.
F4 The non-qualified stock option was granted as a premium-price stock option. To calculate the premium exercise price for each tranche we used the closing price on February 28, 2023 of $63.37 and multiplied by 15% for tranche 1, 25% for tranche 2 and 30% above for tranche 3.
F5 The non-qualified stock option was granted as a premium-price stock option. 40,373 shares will vest and become exercisable on February 28, 2024 with an exercise price of $72.88, 45,104 shares will vest and become exercisable on February 28, 2025 with an exercise price of $79.21, and 47,600 shares will vest and become exercisable on February 28, 2026 with an exercise price of $82.38.